Cas No 555-30-6 Name Methyldopa API Antitremor Paralysis Drug Medical Raw Materials

Basic Information
Place of Origin: China
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Your demand
Delivery Time: Negotiation
Payment Terms: D/P, D/A, L/C, T/T
Supply Ability: Negotiation
Cas No: 555-30-6 Ec No: 209-089-2
Name: Methyldopa Synonyms: 2-Amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic Acid; L-Methyl Dopa
Molecular Formula: C10H13NO4 Molecular Weight: 211.22
Melting Point: ≥300 °C Boiling Poin374.44°Ct: 350.89°C
Solubility: 10g/L(temperature Not Stated) Density: 1.2545 G/cm3
Risk Codes: N/A Safety Description: N/A
High Light:

555-30-6 Methyldopa API Antitremor


Methyldopa API Antitremor 555-30-6


Name Methyldopa Antitremor 555-30-6

Methyldopa Cas No 555-30-6 API; Antitremor paralysis drug


Name Methyldopa
2-Amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic acid; L-Methyl Dopa
Molecular Formula C10H13NO4
Molecular Weight 211.22
CAS Registry Number 555-30-6
EINECS Number 209-089-2
Melting point ≥300 °C
Boiling point 350.89°C
Solubility 10g/L(temperature not stated)
Density 1.2545 g/cm3
Safety Description N/A
Risk Codes N/A


Product Description:


Methyldopa, antihypertensive drugs, alpha agonists, commonly used in tablet form. This product is an exciting vascular movement center of the α -receptor, thereby inhibiting the diplomatic sensory nerve, producing antihypertensive effect, accompanied by slowing down the heart rate, reduce cardiac output, small artery dilation, peripheral vascular resistance significantly reduced, long-term application of cardiac output reduction is not obvious. Clinical use for moderate, severe or malignant hypertension, especially for secondary hypertension, gestational hypertension, heart failure with hypertension, coronary heart disease with hypertension and elderly patients with hypertension.


Product Use:


Levomethyldopa is a B- receptor - blocking cardioascular drug with good efficacy in moderate - stage primary and renal hypertension.


Cas No 555-30-6 Name Methyldopa  API Antitremor Paralysis Drug 	Medical Raw Materials 0Cas No 555-30-6 Name Methyldopa  API Antitremor Paralysis Drug 	Medical Raw Materials 1


Product Catalogue:


Number Cas Name
1 103-90-2 Acetaminophen
2 51481-61-9 Cimetidine
3 124832-26-4 Valaciclovir
4 315-30-0 Allopurinol
5 22839-47-0 Aspartame
6 90045-36-6 Ginkgo biloba extract
7 73-31-4 Melatonine
8 8049-47-6 Pancreatin
9 70-55-3 p-Toluenesulfonamide
10 N/A Ox Gallbladder powde
11 555-30-6 Methyldopa
12 58-93-5 Hydrochlorothiazide
13 76095-16-4 Enalapril maleate
14 69-72-7 Salicylic acid
15 126-07-8 (+)-Griseofulvin
16 73231-34-2 Florfenicol



About us



Zhejiang chemical import and export co., LTD. (zhejiang), formerly known as zhejiang branch of China national chemical import and export corporation, was established in December 1980. In 1988, he was transferred from Sinochem Corporation to be in charge of Zhejiang Provincial Department of Commerce and was renamed Zhejiang Chemical Import and Export Company. In 2003, the company changed its name to Zhejiang Chemical Import and Export Co., Ltd after the reform of state-owned enterprise shareholding system.

In 2008, it was incorporated into Zhejiang International Trade Group (one of the top 500 enterprises in China) and became the core member of the group's business circulation sector. The registered capital of the company is 72.5 million yuan, of which 38% are owned by the state and 62% are owned by employees.
There are 195 employees in the company, more than 79% of whom have bachelor's degree, 36% of whom are graduate students, and more than 90% of the salesmen have pharmaceutical and chemical background. The company is mainly engaged in the import and export trade of pharmaceutical raw materials and intermediates, dyes, pesticides, basic chemicals, fine chemicals, food and feed additives, pharmaceutical preparations and other products. The company has established close economic and trade relations with more than 100 countries and regions around the world. The company has wholly-owned subsidiaries Ruike International Trade Co., Ltd., Zhejiang Ruikai Chemical Co., Ltd., Zhejiang Fukai Import and Export Co., Ltd., joint-stock enterprise Zhejiang Aotokang Pharmaceutical Group Co., Ltd.
In recent years, especially since the establishment of the new team in 2019, the company has adhered to the development led by the party building, energized by reform, and improved efficiency by management. The company has shown a steady upward momentum of development. In 2020, the company achieved revenue of 3.337 billion yuan, total profit of 56.12 million yuan, total import and export of 450 million dollars.

In 2019, the company was rated as China Council for the Promotion of International Trade (CCPIT) Recommended Certification Enterprise, Top 100 International Pharmaceutical Enterprises -- a high-quality supplier and partner in the international market; In 2020, Zhejiang Provincial Department of Commerce and other units rated as the province's epidemic prevention and medical materials import outstanding contribution enterprise, Zhejiang Provincial Tax Bureau identified as the export tax rebate enterprises.


Contact Details
William Wang

Phone Number : +86-13588430486

WhatsApp : +8613588430486